| mRNA |
dabrafenib |
GDSC1000 |
pan-cancer |
AAC |
0.19 |
5e-08 |
| mRNA |
RDEA119 |
GDSC1000 |
pan-cancer |
AAC |
0.18 |
3e-07 |
| mRNA |
PD-0325901 |
GDSC1000 |
pan-cancer |
AAC |
0.18 |
3e-06 |
| mRNA |
1S,3R-RSL-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
4e-06 |
| mRNA |
Erlotinib |
CCLE |
pan-cancer |
AAC |
0.23 |
6e-06 |
| mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
8e-06 |
| mRNA |
AZD7762 |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
9e-06 |
| mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-05 |
| mRNA |
PD-0325901 |
CCLE |
pan-cancer |
AAC |
0.21 |
2e-05 |
| mRNA |
ML162 |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
2e-05 |